Bionime Corporation
Native name | 華廣生技股份有限公司 |
|---|---|
Romanized name | HuaKuang ShengJih GuFeng YouHsian GongShi |
| Public | |
| Traded as | TWSE: 4737 |
| ISIN | 🆔 |
| Industry | Medical Device |
| Founded 📆 | 29 April 2003 |
| Founder 👔 | Roy Chun-Mu Huang 黃椿木[1] |
| Headquarters 🏙️ | No. 100, Section 2, Daqing St, South District, Taichung City, 402, , |
Area served 🗺️ | |
Key people | Roy Chun-Mu Huang, Chairman, Lien Te-Lung, Vice President |
| Products 📟 | |
| Revenue🤑 | NT$2,172,923,000 (2019)[2] |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Bionime[3] is a medical equipment corporation headquartered in TaiChung Taiwan. It mainly focuses on diabetes equipment such as blood glucose monitors. It's main competitors in the global blood glucose monitor market includes Abbott, Roche, Bayer AG, B. Braun Melsungen AG, Nipro Diagnostics Inc., Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical[4]. It has company locations in Switzerland, China, and the US. Bionime also serves as an original design manufacturer for other companies.[5]
As of 2018, Bionime's revenue is split between blood glucose meters (BGMs) (10%), strips (87%), and others (3%). As for geographic sales regions, Europe accounted for 29%, Asia 32%, Americas 9%, and 30% in other territories. It boasts of test strip production capacity of 530 million strips a year.[6] Bionime uses electro-chemical biosensing as its core technology for blood glucose detection, different from other screen printed carbon electrode (SPCE) test strips. Its products are mainly marketed under its own brand BIONIME. In addition to its own research and development of embedded precious metal electrodes, it also develops its own fully automatic production equipment, much like other companies such as Taiwan Semiconductor Manufacturing Company.
In order to reduce the cost impact of the US medical reform policy, the company cooperated with Sinocare (300298.SZ), the third largest blood glucose testing equipment company in mainland China on February 2014, with Sinocare acquiring 20% stock share for 132 million taiwanese dollars, and the Chinese hospital and retail market channels.
History[edit]
Bionime was founded at Dali City, Taichung County on April 2003.
In 2005, launched their first glucose monitor.
In 2008, they announced a new US retail initiative with Ypsomed.[7]
December 2010, officially listed on the Taiwan Stock Exchange and traded under stock code 4737.
In 2012, Bionime entered into a multi-year agreement with GE, to provide GE-branded diabetes equipment for the market.[8]In 2014, launched GE-branded glucose monitoring product.[9]
In August 2015, Bionime and Tonghua Dongbao (600867.SH) signed an agreement to become the only and exclusive authorized distributor in mainland China, and obtained 17.8% equity.
In 2019, Bionime began to invest in the CGM market[10], as of October 2019.[11]
Publications[edit]
- Systems for Self-Testing: System Accuracy and Measurement Reproducibility[12]
- Evaluation of Blood Glucose Monitors and Accuracy[13]
- Evaluation of Blood Glucose Monitoring System in Screening for Neonatal Hypoglycemia: Tighter Accuracy Standard[14]
- Evaluation of 27 Blood Glucose Monitors[15]
- Accuracy Evaluation of 19 Blood Glucose Monitoring Systems Manufactured in the Asia-Pacific Region: A Multicenter Study[16]
See also[edit]
References[edit]
- ↑ "Bloomberg - Are you a robot?". www.bloomberg.com.
- ↑ "Bloomberg - Are you a robot?". www.bloomberg.com.
- ↑ "Rightest blood glucose meter - Bionime Global". www.bionime.com.
- ↑ Markets, Research and (February 15, 2016). "Global Self-Monitoring Blood Glucose (SMBG) Devices Market to 2022 - Strips Dominated Market with 83.5% Share of the $11 Billion Market". GlobeNewswire News Room.
- ↑ "【公告】華廣 2020年2月合併營收1.54億元 年增64.31%". Yahoo奇摩股市.
- ↑ "華廣生技股份有限公司". MoneyDJ理財網.
- ↑ "Bionime Corporation and Ypsomed AG Announce New US Retail Initiative". www.businesswire.com. February 16, 2010.
- ↑ "GE Selects Bionime to Launch Innovative Diabetes Solutions". www.businesswire.com. January 17, 2012.
- ↑ "General Electric : GE200 Blood Glucose Meter Receives GE Healthymagination Validation | MarketScreener". www.marketscreener.com.
- ↑ "Global $13.7 Bn Blood Glucose Monitoring Market Study, 2020-2025". Benzinga.
- ↑ "華廣:澄清說明新聞媒體報導 | Anue鉅亨 - 台股公告". Anue鉅亨. October 17, 2019.
- ↑ Freckmann, Guido; Baumstark, Annette; Schmid, Christina; Pleus, Stefan; Link, Manuela; Haug, Cornelia (November 8, 2013). "Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility". Diabetes Technology & Therapeutics. 16 (2): 113–122. doi:10.1089/dia.2013.0208. PMID 24205978.
- ↑ http://www.tsim.org.tw/journal/jour27-5/03.PDF
- ↑ Tsao, Mei-Fen; Chang, Hui-Wen; Chang, Chien-Hsi; Cheng, Chi-Hsuan; Lin, Hsiu-Chen (May 1, 2017). "Evaluation of Blood Glucose Monitoring System in Screening for Neonatal Hypoglycemia: Tighter Accuracy Standard". Journal of Diabetes Science and Technology. 11 (3): 639–640. doi:10.1177/1932296816668878. PMC 5505412. PMID 27633318.
- ↑ Freckmann, Guido; Baumstark, Annette; Jendrike, Nina; Zschornack, Eva; Kocher, Serge; Tshiananga, Jacques; Heister, Frank; Haug, Cornelia (2010). "System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197". Diabetes Technology & Therapeutics. 12 (3): 221–231. doi:10.1089/dia.2009.0128. PMID 20151773.
- ↑ Yu-Fei, Wang; Wei-Ping, Jia; Ming-Hsun, Wu; Miao-O, Chien; Ming-Chang, Hsieh; Chi-Pin, Wang; Ming-Shih, Lee (May 8, 2017). "Accuracy Evaluation of 19 Blood Glucose Monitoring Systems Manufactured in the Asia-Pacific Region: A Multicenter Study". Journal of Diabetes Science and Technology. 11 (5): 953–965. doi:10.1177/1932296817705143. PMC 5950995. PMID 28480733.
External links[edit]
- Official website
- Business data for Bionime: Google Finance
- Yahoo! Finance
- Bloomberg
  | This article about a Taiwanese corporation or company is a stub. You can help EverybodyWiki by expanding it. |
This article "Bionime" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Bionime. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
